DARINKA MORALES: Open Payments
NPI 1255853479 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 23 payments from 10 companies in 2025. Trend: 2023 $1,410 · 2024 $1,348 · 2025 $684
Food & beverage: $500Education: $184
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $385 |
| CSL Behring | 2 | $60 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $44 |
| GENZYME CORPORATION | 1 | $37 |
| PFIZER INC. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Amgen Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: DUPIXENT, Haegarda, NEFFY, RINVOQ, CIBINQO, TEZSPIRE, Xhance, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
